Telomir Pharmaceuticals, Inc.
Data quality: 83%
TELO
NASDAQ
Manufacturing
Chemicals
$1.22
▼
$0.04
(-3.17%)
Mkt Cap: 43.66 M
Price
$1.27
Mkt Cap
43.66 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—
Quick Summary
Key Takeaways
Negative free cash flow of -3.69 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-279.15%
Below sector avg (-54.01%)
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio17.51
Interest CoverageN/A
Valuation
PE (TTM)
-4.19
Below sector avg (-1.49)
P/B Ratio6.26
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1385 peers)
Peer Comparison
vs Manufacturing sector median (1385 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -4.2 | -1.5 |
| P/B | 6.3 | 1.6 |
| ROE % | -279.2 | -54.0 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
No forward estimates available
No quarterly estimates available
Earnings Surprises
Last 4 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| Q32025 | -$0.07 | -$0.03 | +57.1% |
| Q22025 | -$0.08 | -$0.17 | -112.5% |
| Q12025 | -$0.10 | -$0.07 | +30.0% |
| Q42024 | -$0.05 | -$0.10 | -100.0% |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -10.41 M |
| ROE | -279.15% | ROA | -253.00% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -3.69 M |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 17.51 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 6.98 M | Tangible Book Value | 6.98 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -4.19 | Forward P/E | N/A |
| P/B Ratio | 6.26 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -8.45% | ||
| Market Cap | 43.66 M | Enterprise Value | 43.66 M |
| Per Share | |||
| EPS (Diluted TTM) | -0.33 | Revenue / Share | N/A |
| FCF / Share | -0.11 | OCF / Share | -0.11 |
| EPS CAGR (1Y) | -158.93% | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 35.42% |
| SBC-Adj. FCF | -8.99 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | — | — | — |
| Net Income | -10.41 M | -16.53 M | -13.07 M |
| EPS (Diluted) | -0.33 | 0.56 | -0.45 |
| Gross Profit | — | — | — |
| Operating Income | — | — | — |
| EBITDA | — | — | — |
| R&D Expenses | 2.44 M | 2.24 M | 1.57 M |
| SG&A Expenses | — | — | — |
| D&A | — | — | — |
| Interest Expense | 4.34 M | 4.34 M | 1.64 M |
| Income Tax | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 7.34 M | 1.32 M | 4.77 M |
| Total Liabilities | 1.43 M | 680,968.0 | 1.34 M |
| Shareholders' Equity | 5.91 M | 643,037.0 | 3.44 M |
| Total Debt | — | — | — |
| Cash & Equivalents | — | — | — |
| Current Assets | 7.34 M | 1.32 M | 435,225.0 |
| Current Liabilities | 1.43 M | 680,968.0 | 1.34 M |
{"event":"ticker_viewed","properties":{"ticker":"TELO","listing_kind":"stock","pathname":"/stocks/telo","exchange":"NASDAQ","country":"US"}}